Most Popular
-
1
Ador CEO denies allegations, accuses Hybe of mistreating NewJeans
-
2
Medical reform committee kicks off despite boycott from doctors
-
3
10-man S. Korea lose to Indonesia to miss out on Paris Olympic football qualification
-
4
Hybe-Ador feud should have limited effect on Hybe's overall performance: analysts
-
5
DP leader says he will meet Yoon without conditions
-
6
Over 9,000 hotline calls made by stalking victims in 2023
-
7
Second Gimpo civil servant found dead, after apologizing for not finishing work
-
8
[Hello India] Hyundai Motor vows to boost 'clean mobility' in India
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](//res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/25/20240425050672_0.jpg&u=)
-
9
Monthly users on local streaming platforms outpace Netflix, Disney+
-
10
US will take steps for three-way engagement on nuclear deterrence with S. Korea, Japan: Campbell
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=644&simg=/content/image/2024/04/25/20240425050672_0.jpg&u=)
[DISCLOSURE] LG Life Science (068870) reported on July 21 that its operating profit rose 208 percent to 10.59 billion won (US$9.27 million) in the second quarter.
Revenue and net profit also increased 26 percent and 787 percent to 130.52 billion won and 7.36 billion won, respectively, its consolidated financial sheets stated.
Revenue and net profit also increased 26 percent and 787 percent to 130.52 billion won and 7.36 billion won, respectively, its consolidated financial sheets stated.
